Peter M. Neupert, a director at Fortrea Holdings Inc. ($FTRE), made two open market purchases of company shares in the last year, totaling $407 thousand. His latest buy occurred on August 11, 2025. These purchases rank 990th among nearly 5,000 individual insiders, trailing the average of $1.46 million across about 3.3 transactions. Neupert reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Common Stock | 15625 | $0.00 | 240,315.0000 | 163,162,107 | 6.95% | 0.01% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | M | Common Stock | 897 | $0.00 | 13,784.0000 | 83,000,000 | 6.96% | 0.00% |
| Feb. 10, 2026 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Aug. 11, 2025 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | P | Common Stock | 32500 | $6.26 | 98,132.0000 | 90,200,000 | 49.52% | 0.04% |
| Aug. 8, 2025 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | P | Common Stock | 30000 | $6.79 | 65,632.0000 | 90,200,000 | 84.19% | 0.03% |
| May 14, 2025 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Chief Executive Officer | A | Restricted Stock Unit | 148536 | $0.00 | 148,536.0000 | 90,200,000 | 9999.99% | 0.16% |
| May 14, 2025 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Chief Executive Officer | M | Restricted Stock Unit | 7282 | $0.00 | 0.0000 | 90,200,000 | 100.00% | 0.01% |
| May 14, 2025 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Chief Executive Officer | M | Common Stock | 7282 | $0.00 | 35,632.0000 | 90,200,000 | 25.69% | 0.01% |
| March 10, 2025 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | M | Common Stock | 50000 | $4.07 | 234,690.0000 | 147,101,648 | 27.07% | 0.03% |
| March 10, 2025 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | M | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 147,101,648 | 100.00% | 0.03% |
| March 10, 2025 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | S | Common Stock | 10000 | $7.05 | 224,690.0000 | 147,101,648 | 4.26% | 0.01% |
| March 4, 2025 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Stock Option (right to buy) | 23726 | $0.00 | 23,726.0000 | 147,101,648 | 9999.99% | 0.02% |
| March 4, 2025 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Common Stock | 15394 | $0.00 | 184,690.0000 | 147,101,648 | 9.09% | 0.01% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | M | Common Stock | 944 | $0.00 | 12,887.0000 | 83,400,000 | 7.90% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| July 18, 2024 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | M | Common Stock | 6354 | $0.00 | 28,350.0000 | 0 | 28.89% | 0.00% |
| July 18, 2024 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | M | Restricted Stock Unit | 6354 | $0.00 | 7,282.0000 | 0 | 46.60% | 0.00% |
| May 14, 2024 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | A | Restricted Stock Unit | 7282 | $0.00 | 13,636.0000 | 0 | 114.61% | 0.00% |
| March 12, 2024 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | M | Common Stock | 15000 | $0.84 | 169,296.0000 | 144,383,294 | 9.72% | 0.01% |
| March 12, 2024 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | M | Stock Option (right to buy) | 15000 | $0.00 | 0.0000 | 144,383,294 | 100.00% | 0.01% |
| March 4, 2024 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Stock Option (right to buy) | 48044 | $0.00 | 48,044.0000 | 144,383,294 | 9999.99% | 0.03% |
| March 4, 2024 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Common Stock | 31328 | $0.00 | 154,296.0000 | 144,383,294 | 25.48% | 0.02% |
| Feb. 6, 2024 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | M | Common Stock | 947 | $0.00 | 11,943.0000 | 83,900,000 | 8.61% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | NEUPERT PETER M | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Dec. 13, 2023 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | M | Common Stock | 100000 | $0.84 | 122,968.0000 | 142,515,917 | 435.39% | 0.07% |
| Dec. 13, 2023 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | M | Stock Option (right to buy) | 100000 | $0.00 | 0.0000 | 142,515,917 | 100.00% | 0.07% |
| Aug. 23, 2023 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | P | Common Stock | 11000 | $25.30 | 21,996.0000 | 0 | 100.04% | 0.00% |
| July 18, 2023 | Fortrea Holdings Inc. | $FTRE | NEUPERT PETER M | Director | A | Restricted Stock Unit | 6354 | $0.00 | 6,354.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Common Stock | 14775 | $0.00 | 22,968.0000 | 142,515,917 | 180.34% | 0.01% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | NEUPERT PETER M | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |